Over the last couple of decades, the role of our animal companions in our lives has increased.
By doing so, we believe that instead of the typical 5% to 10% success rate seen with new chemical entities in traditional drug development, we can achieve 50% to 70% success rate.
In addition, we focus on efficiency and develop most of our therapeutics for an average of approximately $5 million in only 3 to 5 years. Typically, veterinary drugs reach peak sales between $10 million and $100 million per year; therefore, we believe that the return on investment is very attractive.
We are a pioneer in the animal biotech field, and we are fortunate to have one of the best scientific teams and pipelines in the industry. Our goal is to continue to build on our leadership and leverage opportunities in veterinary medicine to meet unmet needs for our animal companions.
1 American Pet Products Association. [Access Date: January 29, 2018]. Available from: http://www.americanpetproducts.org/press_industrytrends.asp